SCHEMBL32665503

SCHEMBL32665503

CN(C)C(=O)c1ccc(CN)c(O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 5/20 0.42
HSP90AB1 P08238 4/20 0.42
ERN1 O75460 3/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAOB P27338 1/20 0.41
AOC3 Q16853 1/20 0.41
PDK2 Q15119 4/20 0.41
LOX P28300 2/20 0.40
KIF11 P52732 2/20 0.39
PDK4 Q16654 3/20 0.38
PDK1 Q15118 2/20 0.38
PDK3 Q15120 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
KDM4E B2RXH2 1/20 0.37
CA12 O43570 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9346007 0.80 CA12 (0.59) ALDH1A1HPGDSMN1; SMN2KDM4ECA12
SCHEMBL9131982 0.77 CA12 (0.56) HSP90AA1HSP90AB1ERN1ALDH1A1HPGD
SCHEMBL13205433 0.77 PDK2 (0.47) HSP90AA1HSP90AB1ERN1ALDH1A1HPGD
SCHEMBL29447970 0.77 PDK2 (0.47) HSP90AA1HSP90AB1ERN1ALDH1A1HPGD
SCHEMBL32665581 0.75 PTGS1 (0.42) HSP90AA1HSP90AB1ERN1ALDH1A1HPGD
SCHEMBL15173317 0.75 HSP90AA1 (0.45) HSP90AA1HSP90AB1ALDH1A1HPGDSMN1; SMN2
SCHEMBL19454508 0.74 HSP90AA1 (0.44) HSP90AA1HSP90AB1ERN1ALDH1A1HPGD
SCHEMBL16104655 0.73 TAAR1 (0.42) ALDH1A1HPGDSMN1; SMN2MAOBAOC3
SCHEMBL4847261 0.73 NCEH1 (0.45) ERN1ALDH1A1HPGDMAOBAOC3
SCHEMBL355413 0.73 ESR1 (0.60) HSP90AA1HSP90AB1ERN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A HSP90AA1 1275/4885HSP90AB1 814/4885ERN1 1510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.